Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Gary T. Elliott"'
Publikováno v:
Cancer Biology & Therapy, Vol 23, Iss 1, Pp 117-126 (2022)
Mitochondria are key tumor drivers, but their suitability as a therapeutic target is unknown. Here, we report on the preclinical characterization of Gamitrinib (GA mitochondrial matrix inhibitor), a first-in-class anticancer agent that couples the He
Externí odkaz:
https://doaj.org/article/323440b459744844bcf3002c13b30f4e
Autor:
Que Liu, Peter R. Kowey, Tengxian Liu, Donglin Guo, Mireille Gingras, Gan-Xin Yan, Gary T. Elliott
Publikováno v:
Journal of Cardiovascular Pharmacology. 57:79-85
HBI-3000 (sulcardine sulfate) has been shown to suppress various ventricular arrhythmias in animal models. The electrophysiological properties of HBI-3000 were investigated using standard microelectrode and patch-clamp techniques in single human vent
Autor:
Noopur Raje, Enrique M. Ocio, Simona Blotta, Teru Hideshima, Catley P. Laurence, Hiroshi Yasui, Paola Neri, Gary T. Elliott, Kenneth C. Anderson, Sarath Kanekal, Tanyel Kiziltepe, Pierfrancesco Tassone, Kenji Ishitsuka, Nikhil C. Munshi, Mariateresa Fulciniti
Publikováno v:
British Journal of Haematology. 134:37-44
SummaryGlucocorticoids have been widely used in the treatment of multiple myeloma(MM) both as single agents and in combination with other drugs. However,primary or acquired glucocorticoid resistance occurs in most cases. It wasrecently reported that
Autor:
Gary T. Elliott, Kenji Ishitsuka, Shaji Kumar, Klaus Podar, Noopur Raje, Nikhil C. Munshi, Lorenzo M. Leoni, Aldo M. Roccaro, Pierfrancesco Tassone, Teru Hideshima, Kenneth C. Anderson, Norihiko Shiraishi, Makoto Hamasaki, Sarath Kanekal, Dharminder Chauhan, Yu-Tzu Tai, Hiroshi Yasui
Publikováno v:
Blood. 106:706-712
In this study we report that R-etodolac (SDX-101), at clinically relevant concentrations, induces potent cytotoxicity in drug-sensitive multiple myeloma (MM) cell lines, as well as in dexamethasone (MM.1R)-, doxorubicin (Dox40/RPMI8226)-, and bortezo
Publikováno v:
Journal of Cardiovascular Pharmacology. 32:337-342
Summary: We sought to determine the role of opening of adenosine triphosphate (ATP)-sensitive potassium channel (KATP channel) in monophosphoryl lipid A (MLA)-induced myocardial protection after ischemia/reperfusion (I/R) in rabbit. We used 5-hydroxy
Autor:
Gary T. Elliott
Publikováno v:
Journal of Molecular and Cellular Cardiology. 30:3-17
Monophosphoryl lipid A represents a novel agent capable of enhancing myocardial tolerance to ischemia/reperfusion injury. This cardioprotective activity of MLA manifests itself as a reduction in infarct size, myocardial stunning and dysrhythmias in m
Autor:
Mohammed A. Nayeem, Gary T. Elliott, Rakesh C. Kukreja, Maulik Shah, Samantha L Hastillo-Hess
Publikováno v:
Journal of Molecular and Cellular Cardiology. 29:2305-2310
We examined the in vitro preconditioning effect of non-toxic derivative of endotoxin, monophosphoryl lipid A (MLA) in adult rat cardiac myocytes. Cultured 5-7-day-old myocytes were preconditioned for 4 h by treatment with 200 ng/ml MLA. Twenty h late
Autor:
Gary T. Elliott
Publikováno v:
Annals of the New York Academy of Sciences. 793:386-399
As the mechanism of ischemic preconditioning unfolds, various strategies for inducing pharmacologic preconditioning become apparent. Adenosine receptor agonists, KATP channel activators, and endothelial-neutrophil adhesion antagonists have enjoyed ca
Publikováno v:
Pharmacology. 51:152-159
The effects of a 1- or 24-hour pretreatment regimen with monophosphoryl lipid A (MLA, 35 micrograms/kg i.v.) on myocardial stunning produced by repetitive coronary occlusions were studied in barbital-anesthetized dogs. Regional segment function (%SS)
Publikováno v:
Journal of Immunotherapy. 10:69-74
Mice are relatively resistant to the lethal effects of endotoxin. Sensitivity to lipopolysaccharide (LPS) and monophosphoryl lipid A (MPL) can be enhanced by concurrently loading animals with D-galactosamine (D-gal). Significant diurnal variation in